Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s43856-024-00664-y
PubMed Identifier: 39562612
Publication URI: http://europepmc.org/abstract/MED/39562612
Type: Journal Article/Review
Volume: 4
Parent Publication: Communications medicine
Issue: 1
ISSN: 2730-664X